Comparative histopathology of grey-horse-melanoma and human malignant melanoma

Pigment Cell Research

Volumn 17, Issue 6, 2004, Pages 674-681

  Seltenhammer, Monika Heidemarie ^a   Heere Ress, Elisabeth ^b   Brandt, Sabine ^a,b   Druml, Thomas ^c   Jansen, Burkhard ^b   Pehamberger, Hubert ^b   Niebauer, Gert Willhelm ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Apoptosis; Grey horse melanoma; Histopathology; Human blue nevi; Human desmoplastic melanoma; Human malignant melanoma; Immunohistochemistry

Indexed keywords

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLUE NEVUS; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HORSE DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; NONHUMAN; SKIN CANCER;

ANIMALS; HORSES; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM METASTASIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 9244245193     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00192.x     Document Type: Article

References (43)

1. Gebhart W, Niebauer GW. Beziehungen zwischen Pigmentschwund und Melanomatose am Beispiel des Lipizzanerschimmels. Arch Dermatol Res 1977;259:29-42
2. Mayr B, Niebauer GW, Gebhart W, Hofecker G, Kügl A, Schleger W. Untersuchungen an peripheren Leukozyten melanomtragender und melanomfreier Schimmelpferde verschiedener Altersstufen. Zbl Vet Med, A 1979;26:417-427
3. Desser H, Niebauer GW, Gebhart W. Polyamin-und Histamingehalt im Blut von pigmentierten, depigmentierten und melanomtragenden Lipizzanerpferden. Zbl Vet Med, A 1980;27:45-53
4. Niebauer GW. Das Melanom beim Schimmelpferd - klinische Aspekte und biologisches Krebsmodell. 7. Arbeitstag. Fachgr.: Pferdekrankh., Hamburg, 1-3 October, 1980. pp. 253-257
5. Fleury C, Bèrard F, Leblond A, Faure C, Ganem N, Thomas L. The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): epidemiological survey. Pigment Cell Res 2000;13:47-51
6. Valentine BA. Equine melanotic tumors: a retrospective study of 53 horses (1988-1991). J Vet Int Med 1995;9:291-297
7. Jeglum KA. Melanomas. In: Robinson NE, ed. Current Therapy in Equine Medicine, 4th edn. Philadelphia, PA: WB Saunders Co., 1999. pp. 399-400
8. MacGillivray KC, Sweeney RW, Del Piero F. Metastatic melanoma in horses. J Vet Intern Med 2002;16:452-456
9. Altmeyer P, Holzmann H, Stöhr L, Koch HJ. The relationship between α-MSH level and coat color in white Camargue horses. J Invest Dermatol 1984;82:199-201
10. Rieder S, Stricker C, Joerg H, Dummer R, Stranzinger G. A comparative genetic approach for the investigation of ageing grey horse melanoma. J Anim Breed Genet 2000;117:73-82
11. Honnas CM, Liskey CC, Meagher DM, Brown D, Luck EE. Malignant melanoma in the foot of a horse. J Am Vet Med Assoc 1990;197:756-758
12. Seltenhammer MH. Vergleichende Untersuchungen zum equinen und humanen Melanom. PhD Thesis. Vienna, Austria: University of Veterinary Medicine; 2000
13. Seltenhammer MH, Simhofer H, Scherzer S, Zechner P, Curik I, Sölkner J, Brandt SM, Jansen B, Pehamberger H, Eisenmenger E. Equine melanoma in a Population of 296 grey Lipizzan horses. Equine Vet J 2003;in press
14. SAS Institute Inc. SAS/STAT Software: Changes and Enhancements Through Release 8.02. Cary, NC: SAS Institute Inc.; 2001
15. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:60-65
16. Levene A. Disseminated dermal melanocytosis terminating in melanoma. Brit J Dermatol 1979;101:197-205
17. Rodriguez M, Garcia-Barona J, Pera L, Castano M, Rodriguez A. Grey horse melanotic condition: a pigmentary disorder. J Equ Vet Sci 1997;17:677-681
18. Clark WH Jr, Elder DE, Guerry D IV, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Human Pathol 1984;15:1147-1165
19. Braun-Falco O, Landthaler M, Hölzel D, Konz B, Schmoeckel C. Klassifizierung, Diagnose und Differenzialdiagnose maligner Melanome. Chir 1986;57:593-600
20. Mancianti ML, Clark WH, Hayes FA, Gerlyn M. Malignant melanoma stimulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. Am J Pathol 1990;151:1105-1113
21. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707
22. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440
23. Fleury C, Bérard F, Balme B, Thomas L. The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): clinical-pathological characterization. Pigment Cell Res 2000;13:46-47
24. Newton Bishop JA. Molecular pathology of melanoma. Cancer Metas Rev 1997;16:141-154
25. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004;140:99-103
26. Jain S, Allen PW. Desmoplastic malignant melanoma and its variant: a study of 45 cases. Am J Surg Pathol 1989;13:358-373
27. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996;20:1489-1500
28. Clark WH. Jr Tumor progression and the nature of cancer. Br Assoc Cancer Res 1991;64:634-644
29. Ackermann AB, Mihara I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol 1985;16:87-91
30. Hofbauer GFL, Kamarasher J, Geertsen R, Böni R, Dummer R. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cut Pathol 1998;25:204-209
31. Hanson IM, Banerjee SS, Menase LP, Prescott RJ. A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features. Histopathology 2002;40:187-195
32. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB45 in malignant melanoma and melanoma variants. Histopathol 1998;32:139-146
33. Orchark GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2001;32:475-481
34. Roels S, Tilmant K, Van Daele A, Van Marck E, Ducatelle R. Proliferation, DNA ploidy, p54 overexpression and nuclear DNA fragmentation in six equine melanocytic tumours. J Vet Med A 2000;47:439-448
35. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathol 1990;17:489-503
36. Hall PA, Levision DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP. Proliferation Cell Nuclear Antigen (PCNA) immunolocalisation in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294
37. Hall PA, McKee PH, Menage H, Du P, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8:203-207
38. Landberg G, Roos G. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Cytometry 1992;13:230-240
39. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathol 1992;21:591-594
40. Kelamn Z. PCNA: Structure, functions and interactions. Oncogene 1997;14:629-640
41. Moretti S, Pinzi C, Berti E, Spallanzani A, Chiarugi A, Boddi UM, Giannotti B. In situ expression of transforming growth factor β is associated with melanoma progression and correlates with Ki-67, HLA-DR and β3 integrin expression. Melanoma Res 1997;7:313-321
42. Ichikawa T, Maumoto J, Kaneko M, Saida T, Sagara J, Taniguchi S. Moesin and CD44 expression in cutaneous melanotic tumors. Brit J Dermatol 1998;138:763-768
43. Schaider H, Soyer HP, Heider KH, Hofman-Wellenhof R, Zatloukal K, Smolle J, Kerl H. CD44 and variants in melanocytic skin neoplasms. J Cutan Pathol 1998;25:199-203